HEATHER BENEDETTO: Open Payments
NPI 1336209097 · ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 28 payments from 9 companies in 2025. Trend: 2023 $100 · 2024 $134 · 2025 $671
Food & beverage: $572Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $336 |
| ABBVIE INC. | 4 | $84 |
| Ardelyx, Inc. | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| EVOKE PHARMA, INC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: TREMFYA, IBSRELA, XIFAXAN, CREON, DUPIXENT, RINVOQ, EOHILIA, VELSIPITY.
Industry payments across MA — which companies pay providers there.
